LongStock1 hour agoFor new Mesoblast investors:Remestemcel-L has...

LongStock1 hour ago

For new Mesoblast investors:
Remestemcel-L has basically been around for over 10 years and it has been through a half dozen trials with diseases like GvHD, Crohns, Cardiac and Diabetes thus getting the kinks worked out all the while. Then in 2013, along comes Mesoblasts with the perfect timing and who buys this product from Osiris Therapeutics. Mesoblast wisely added this product to their development initiatives, combining and taking advantage of the Intellectual Properties (IP) and patents they had aquired.

One of the characteristics that remestemcel-L has always shown throughout all this time is that it "reduces inflammation". Now, here we are faced with the Covid-19 pandemic and find that about 19% of these virus infected people develop Acute respiratory distress syndrome (ARDS), more simply said; "lung inflammation" and where moritality is about 90% for these unlucky patients.

Mesoblast's CEO, Dr. Silviu Itescu and his team quickly recognized the similarity between Covid-19 ARDS and the lung inflammation as seen in these other trials and presented a case to the FDA suggesting a compassionate trial using remestemcel-L on 12 ARDS patients. This was quickly done and results were that 75% of these ARDS patients were taken off ventilators in a medium time of 10 days and their lives were spared. After that the FDA asked for a larger 300 patient trial to confirm these results and they further agreed to an early read-out on the first 90 patients. This early read-out is scheduled for "early" in September and if as successful as the first small trial they will end this larger trial early.

If remestemcel-L replicates the success of the first small trial then Mesoblast could be literally saving thousands of lives within the next couple of months. The latest Covid-19 statistics show over 60,000 new cases daily in the USA and if 19% of them progress onto ARDS like the numbers previously suggest then Mesoblast is going to be very busy shipping out remestemcel-L to every hospital in the USA.

Glta & DYOR!